Sequencing studies and mechanistic investigations have revealed alterations in GI-related genes and events (e.g., TP53, BRCA1/2, RB1 loss, CDKN2A loss) relevant in cancer progression [12,30]. This evidence concerns the gene BRCA1 and cancer.